Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions

被引:4
|
作者
Kang, Gyeong Hoon [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea
关键词
ISLAND METHYLATOR PHENOTYPE; POPULATION-BASED SAMPLE; SPORADIC COLON-CANCER; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; SERRATED POLYPS; LYNCH SYNDROME; CLINICOPATHOLOGICAL FEATURES; CPG-ISLANDS; MUTATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-In addition to chromosomal instability and microsatellite instability (MSI), a third pathway, epigenetic instability, has been implicated in progression to colorectal carcinogenesis. CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that occur through the epigenetic instability pathway and that are characterized by widespread hypermethylation of promoter CpG island loci, resulting in the inactivation of several tumor suppressor genes or tumor-related genes. Colorectal cancers can be classified into 4 molecular subtypes according to their CIMP and MSI statuses: CIMP+/MSI+, CIMP+/MSI-, CIMP-/MSI+, and CIMP-/MSI-. There are differences between Western (United States and European Union) and Eastern (Korea and China) populations in the number of CRCs that are MSI+, and in the number of MSI+ CRCs that are CIMP+. Objective.-To review the clinicopathologic and molecular features of the 4 molecular subtypes of CRCs and their precursor lesions, and to emphasize geographic differences in CRCs between Eastern and Western populations. Data Sources.-This article is based on the author's own experimental data and a literature review of relevant articles indexed in PubMed (US National Library of Medicine). Conclusion.-The 4 molecular subtypes of CRC that are defined by their CIMP and MSI statuses are characterized by their own distinct clinicopathologic and molecular features and precursor lesions. In particular, the clinicopathologic features of MSI+ CRCs differ depending on the CIMP status. Further understanding of the heterogeneity in CRC molecular pathways may help to explain the diverse morphologic features of CRCs. (Arch Pathol Lab Med. 2011;135:698-703)
引用
收藏
页码:698 / 703
页数:6
相关论文
共 50 条
  • [1] Immunological profiling of human colorectal cancer defines four distinct molecular subtypes
    You, Weiqiang
    Cai, Du
    Lv, Minyi
    Hu, Peishan
    Gao, Feng
    Wu, Xiaojian
    GUT, 2023, 72 (SUPPL_1) : A128 - A129
  • [2] The consensus molecular subtypes of colorectal cancer
    Justin Guinney
    Rodrigo Dienstmann
    Xin Wang
    Aurélien de Reyniès
    Andreas Schlicker
    Charlotte Soneson
    Laetitia Marisa
    Paul Roepman
    Gift Nyamundanda
    Paolo Angelino
    Brian M Bot
    Jeffrey S Morris
    Iris M Simon
    Sarah Gerster
    Evelyn Fessler
    Felipe De Sousa E Melo
    Edoardo Missiaglia
    Hena Ramay
    David Barras
    Krisztian Homicsko
    Dipen Maru
    Ganiraju C Manyam
    Bradley Broom
    Valerie Boige
    Beatriz Perez-Villamil
    Ted Laderas
    Ramon Salazar
    Joe W Gray
    Douglas Hanahan
    Josep Tabernero
    Rene Bernards
    Stephen H Friend
    Pierre Laurent-Puig
    Jan Paul Medema
    Anguraj Sadanandam
    Lodewyk Wessels
    Mauro Delorenzi
    Scott Kopetz
    Louis Vermeulen
    Sabine Tejpar
    Nature Medicine, 2015, 21 : 1350 - 1356
  • [3] The consensus molecular subtypes of colorectal cancer
    Guinney, Justin
    Dienstmann, Rodrigo
    Wang, Xin
    de Reynies, Aurelien
    Schlicker, Andreas
    Soneson, Charlotte
    Marisa, Laetitia
    Roepman, Paul
    Nyamundanda, Gift
    Angelino, Paolo
    Bot, Brian M.
    Morris, Jeffrey S.
    Simon, Iris M.
    Gerster, Sarah
    Fessler, Evelyn
    Melo, Felipe De Sousa E.
    Missiaglia, Edoardo
    Ramay, Hena
    Barras, David
    Homicsko, Krisztian
    Maru, Dipen
    Manyam, Ganiraju C.
    Broom, Bradley
    Boige, Valerie
    Perez-Villamil, Beatriz
    Laderas, Ted
    Salazar, Ramon
    Gray, Joe W.
    Hanahan, Douglas
    Tabernero, Josep
    Bernards, Rene
    Friend, Stephen H.
    Laurent-Puig, Pierre
    Medema, Jan Paul
    Sadanandam, Anguraj
    Wessels, Lodewyk
    Delorenzi, Mauro
    Kopetz, Scott
    Vermeulen, Louis
    Tejpar, Sabine
    NATURE MEDICINE, 2015, 21 (11) : 1350 - 1356
  • [4] In Situ DESI-MSI Lipidomic Profiles of Breast Cancer Molecular Subtypes and Precursor Lesions
    Santoro, Adriana Leandra
    Drummond, Rodrigo D.
    Silva, Israel Tojal
    Ferreira, Severino S.
    Juliano, Luiz
    Vendramini, Pedro H.
    da Costa Lemos, Monique Batista
    Eberlin, Marcos N.
    Andrade, Victor Piana
    CANCER RESEARCH, 2020, 80 (06) : 1246 - 1257
  • [5] Molecular precursor lesions in oesophageal cancer
    Montesano, R
    Hainaut, P
    CANCER SURVEYS, 1998, 32 : 53 - 68
  • [6] Simple classifiers for molecular subtypes of colorectal cancer
    Kim, Woo Gyeong
    Kim, Joo Yeon
    Park, Do Youn
    ARAB JOURNAL OF GASTROENTEROLOGY, 2017, 18 (04) : 191 - 200
  • [7] Clinical relevance of colorectal cancer molecular subtypes
    Rodriguez-Salas, Nuria
    Dominguez, Gema
    Barderas, Rodrigo
    Mendiola, Marta
    Garcia-Albeniz, Xabier
    Maurel, Juan
    Feliu Batlle, Jaime
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 109 : 9 - 19
  • [8] Identifying the Consensus Molecular Subtypes of Colorectal Cancer
    Vermeulen, L.
    JOURNAL OF PATHOLOGY, 2016, 240 : 7 - 7
  • [9] Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients
    Arakawa, Keiichi
    Hata, Keisuke
    Nozawa, Hiroaki
    Kawai, Kazushige
    Tanaka, Toshiaki
    Nishikawa, Takeshi
    Sasaki, Kazuhito
    Shuno, Yasutaka
    Kaneko, Manabu
    Hiyoshi, Masaya
    Emoto, Shigenobu
    Murono, Koji
    Sonoda, Hirofumi
    Okada, Satoshi
    Ishihara, Soichiro
    ANTICANCER RESEARCH, 2019, 39 (03) : 1425 - 1432
  • [10] A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry
    Li, Xingru
    Larsson, Par
    Ljuslinder, Ingrid
    Ling, Agnes
    Lofgren-Burstrom, Anna
    Zingmark, Carl
    Edin, Sofia
    Palmqvist, Richard
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 220